We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > IND Application

News List

FDA Accepts BrainStorm’s NurOwn IND Application for Progressive Multiple Sclerosis americanpharmaceuticalreview
December 19, 2018
BrainStorm Cell Therapeutics announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application to.....
Eiger Announces FDA Acceptance of IND Application for Lonafarnib americanpharmaceuticalreview
December 05, 2018
Eiger BioPharmaceuticals announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for lonafarnib....
FDA Accepts BeyondSpring IND Application for Plinabulin for the Prevention of Chemotherapy-Induced N americanpharmaceuticalreview
January 25, 2017
BeyondSpring Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's Investigational New Drug (IND) application to initiate Phase 2 / 3 trials for its innovative lead asset, Plinabulin.